AXIM BIOTECHNOLOGIES, INC. (15) | Business Finance (9)
Browse by Subcategory
Recent Contracts
-
Asset Purchase Agreement dated August 26, 2021, by and between AXIM Biotechnologies, Inc. and Advanced Tear Diagnostics, LLC
(Filed With SEC on April 15, 2022)
-
Binding Term Sheet Agreement dated August 3, 2021, by and between AXIM Biotechnologies, Inc. and Advanced Tear Diagnostics, LLC
(Filed With SEC on April 15, 2022)
-
PROMISSORY NOTE
(Filed With SEC on February 16, 2022)
-
AMENDMENT NO. 1 TO STOCK PURCHASE AGREEMENT
(Filed With SEC on December 17, 2019)
-
CONVERTIBLE NOTE
(Filed With SEC on February 16, 2022)
-
AXIM BIOTECHNOLOGIES, INC. 6% CONVERTIBLE REDEEMABLE NOTE DUE SEPTEMBER 29, 2022
(Filed With SEC on February 16, 2022)
-
EQUITY PURCHASE AGREEMENT
(Filed With SEC on May 14, 2021)
-
EQUITY PURCHASE AGREEMENT
(Filed With SEC on May 14, 2021)
-
PREFERRED STOCK PURCHASE AGREEMENT
(Filed With SEC on February 26, 2019)